Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Daniel

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Current Therapeutic Research, Clinical and Experimental|July 28, 2020
The Effect of Propofol on a Forced Swim Test in Mice at 24 HoursDavid G Daniel, Noah G Daniel, Donald T Daniel, et al.
Journal of Psychiatric Research|July 17, 2007
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophreniaJoseph P McEvoy, David G Daniel, William H Carson, et al.
The Journal of Clinical Psychiatry|August 5, 2004
Psychosis in mania: specificity of its role in severity and treatment responseAlan C Swann, David G Daniel, Lisa D Kochan, et al.
Innovations in Clinical Neuroscience|February 22, 2020
The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in MiceDavid G Daniel, Noah G Daniel, Donald T Daniel, et al.
Psychiatric Services (Washington, D.C.)|March 6, 2004
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidoneLeslie Citrome, Daniel E Casey, David G Daniel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophreniaDaniel E Casey, David G Daniel, Adel A Wassef, et al.
The Journal of Emergency Medicine|October 27, 2004
Safety of medications used to treat acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
Schizophrenia Bulletin|June 19, 2010
The brief negative symptom scale: psychometric propertiesBrian Kirkpatrick, Gregory P Strauss, Linh Nguyen, et al.
The Journal of Emergency Medicine|October 27, 2004
Novel therapies for treating acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Future directions in researchGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Current Therapeutic Research, Clinical and Experimental|July 28, 2020
The Effect of Propofol on a Forced Swim Test in Mice at 24 HoursDavid G Daniel, Noah G Daniel, Donald T Daniel, et al.
Journal of Psychiatric Research|July 17, 2007
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophreniaJoseph P McEvoy, David G Daniel, William H Carson, et al.
The Journal of Clinical Psychiatry|August 5, 2004
Psychosis in mania: specificity of its role in severity and treatment responseAlan C Swann, David G Daniel, Lisa D Kochan, et al.
Innovations in Clinical Neuroscience|February 22, 2020
The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in MiceDavid G Daniel, Noah G Daniel, Donald T Daniel, et al.
Psychiatric Services (Washington, D.C.)|March 6, 2004
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidoneLeslie Citrome, Daniel E Casey, David G Daniel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophreniaDaniel E Casey, David G Daniel, Adel A Wassef, et al.
The Journal of Emergency Medicine|October 27, 2004
Safety of medications used to treat acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
Schizophrenia Bulletin|June 19, 2010
The brief negative symptom scale: psychometric propertiesBrian Kirkpatrick, Gregory P Strauss, Linh Nguyen, et al.
The Journal of Emergency Medicine|October 27, 2004
Novel therapies for treating acute agitationGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
The Journal of Emergency Medicine|October 27, 2004
Future directions in researchGlenn W Currier, Michael H Allen, E Bradshaw Bunney, et al.
Pageof 4